Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen C Lazarus

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
The Journal of Allergy and Clinical Immunology|September 15, 2019
Exacerbation-prone asthma in the context of race and ancestry in Asthma Clinical Research Network trialsNicole L Grossman, Victor E Ortega, Tonya S King, et al.
American Journal of Respiratory and Critical Care Medicine|June 19, 2009
An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practiceHelen K Reddel, D Robin Taylor, Eric D Bateman, et al.
American Journal of Respiratory and Critical Care Medicine|November 13, 2012
P2X7-regulated protection from exacerbations and loss of control is independent of asthma maintenance therapyLoren C Denlinger, David M Manthei, Max A Seibold, et al.
Annals of the American Thoracic Society|May 2, 2017
Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study CohortCarlos H Martinez, Susan Murray, R Graham Barr, et al.
Lancet (London, England)|November 26, 2009
Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trialMichael E Wechsler, Susan J Kunselman, Vernon M Chinchilli, et al.
The Journal of Allergy and Clinical Immunology|October 6, 2010
A trial of clarithromycin for the treatment of suboptimally controlled asthmaE Rand Sutherland, Tonya S King, Nikolina Icitovic, et al.
The Journal of Allergy and Clinical Immunology|November 14, 2016
Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatmentJuliana Durack, Susan V Lynch, Snehal Nariya, et al.
The Journal of Allergy and Clinical Immunology|October 3, 2013
Predictors of response to tiotropium versus salmeterol in asthmatic adultsStephen P Peters, Eugene R Bleecker, Susan J Kunselman, et al.
The New England Journal of Medicine|September 6, 2022
Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung FunctionMeiLan K Han, Wen Ye, Di Wang, et al.
The New England Journal of Medicine|October 29, 2010
Tiotropium bromide step-up therapy for adults with uncontrolled asthmaStephen P Peters, Susan J Kunselman, Nikolina Icitovic, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
The Journal of Allergy and Clinical Immunology|September 15, 2019
Exacerbation-prone asthma in the context of race and ancestry in Asthma Clinical Research Network trialsNicole L Grossman, Victor E Ortega, Tonya S King, et al.
American Journal of Respiratory and Critical Care Medicine|June 19, 2009
An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practiceHelen K Reddel, D Robin Taylor, Eric D Bateman, et al.
American Journal of Respiratory and Critical Care Medicine|November 13, 2012
P2X7-regulated protection from exacerbations and loss of control is independent of asthma maintenance therapyLoren C Denlinger, David M Manthei, Max A Seibold, et al.
Annals of the American Thoracic Society|May 2, 2017
Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study CohortCarlos H Martinez, Susan Murray, R Graham Barr, et al.
Lancet (London, England)|November 26, 2009
Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trialMichael E Wechsler, Susan J Kunselman, Vernon M Chinchilli, et al.
The Journal of Allergy and Clinical Immunology|October 6, 2010
A trial of clarithromycin for the treatment of suboptimally controlled asthmaE Rand Sutherland, Tonya S King, Nikolina Icitovic, et al.
The Journal of Allergy and Clinical Immunology|November 14, 2016
Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatmentJuliana Durack, Susan V Lynch, Snehal Nariya, et al.
The Journal of Allergy and Clinical Immunology|October 3, 2013
Predictors of response to tiotropium versus salmeterol in asthmatic adultsStephen P Peters, Eugene R Bleecker, Susan J Kunselman, et al.
The New England Journal of Medicine|September 6, 2022
Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung FunctionMeiLan K Han, Wen Ye, Di Wang, et al.
The New England Journal of Medicine|October 29, 2010
Tiotropium bromide step-up therapy for adults with uncontrolled asthmaStephen P Peters, Susan J Kunselman, Nikolina Icitovic, et al.
Pageof 9